Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.515)

71

Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2024

von Boland, L. | Devresse, A. | Monchaud, C. | +11

72

High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy

enthalten in: International journal of antimicrobial agents | 2024

von Dong, R. | Huang, Y. | Ling, X. | +3

73

Patient Centric Microsampling to Support Paxlovid Clinical Development : Bridging and Implementation

enthalten in: Clinical pharmacology and therapeutics | 2024

von Wan, K. | Kavetska, O. | Damle, B. | +8

CommentIn: Clin Pharmacol Ther. 2024 Jan;115(1):11-13. - PMID 38102787

74

Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19 : A Matched Cohort Study

enthalten in: The Journal of infectious diseases | 2024

von Butt, A. | Yan, P. | Shaikh, O. | +3

75

Daily ritonavir-boosted darunavir for viral suppression in pregnancy (DRV-P)

enthalten in: HIV medicine | 2024

von Gacic, N. | Tulloch, K. | Money, D. | +1

76

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD : Insights from a Single-Center Prospective Cohort Study

enthalten in: Viruses | 2024

von Buchynskyi, M. | Oksenych, V. | Kamyshna, I. | +1

77

Covid-19 : NICE plans to expand Paxlovid eligibility to 1.4 million more people

enthalten in: BMJ (Clinical research ed.) | 2024

von Mahase, E.

78

Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies

enthalten in: Influenza and other respiratory viruses | 2024

von Aiello, T. | Peyrony, O. | Chumbita, M. | +12

79

Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, H. | Zhou, J. | Chen, H. | +10

80

No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

enthalten in: Journal of medical virology | 2024

von Palomino-Cabrera, R. | Tejerina, F. | Molero-Salinas, A. | +9